FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
FRA:1SXP (5/30/2025, 7:00:00 PM)
28.5
+0.4 (+1.42%)
The current stock price of 1SXP.DE is 28.5 EUR. In the past month the price increased by 13.32%. In the past year, price decreased by -2.73%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 18.5 | 134.82B | ||
1TMO.MI | THERMO FISHER SCIENTIFIC INC | 18.11 | 132.03B | ||
DAP.DE | DANAHER CORP | 25.46 | 119.72B | ||
LO3.DE | LONZA GROUP AG-REG | 38.03 | 44.15B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 51.05 | 18.88B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 50.79 | 18.78B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 49.41 | 15.80B | ||
SRT.DE | SARTORIUS AG | 40.42 | 12.92B | ||
ILU.DE | ILLUMINA INC | 24.8 | 11.54B | ||
ERF.PA | EUROFINS SCIENTIFIC | 32.63 | 10.70B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 32.53 | 10.67B | ||
QIA.DE | QIAGEN N.V. | 19.58 | 8.61B |
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4681
Phone: 496131660
The current stock price of 1SXP.DE is 28.5 EUR. The price increased by 1.42% in the last trading session.
The exchange symbol of SCHOTT PHARMA AG& CO KGAA is 1SXP and it is listed on the Deutsche Boerse Ag exchange.
1SXP.DE stock is listed on the Deutsche Boerse Ag exchange.
19 analysts have analysed 1SXP.DE and the average price target is 28.98 EUR. This implies a price increase of 1.68% is expected in the next year compared to the current price of 28.5. Check the SCHOTT PHARMA AG& CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a market capitalization of 4.29B EUR. This makes 1SXP.DE a Mid Cap stock.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4681 employees.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a support level at 24.7 and a resistance level at 28.51. Check the full technical report for a detailed analysis of 1SXP.DE support and resistance levels.
The Revenue of SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is expected to grow by 5.25% in the next year. Check the estimates tab for more information on the 1SXP.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 0.57%. The yearly dividend amount is currently 0.15. Check the full fundamental report for a detailed analysis of 1SXP.DE dividend history, reliability and sustainability.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2025-08-12.
The PE ratio for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is 29.08. This is based on the reported non-GAAP earnings per share of 0.98 and the current share price of 28.5 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1SXP.DE.
ChartMill assigns a technical rating of 8 / 10 to 1SXP.DE. When comparing the yearly performance of all stocks, 1SXP.DE is one of the better performing stocks in the market, outperforming 76.93% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.98. The EPS decreased by -32.93% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 15.17% | ||
ROA | 9.93% | ||
ROE | 17.64% | ||
Debt/Equity | 0.1 |
ChartMill assigns a Buy % Consensus number of 75% to 1SXP.DE. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 4.94% and a revenue growth 5.25% for 1SXP.DE